Patritumab
Patritumab (human anti-ERBB3 recombinant antibody) is a neutralizing monoclonal antibody directed against ERBB3. Patritumab acts synergistically with cetuximab (HY-P9905) to effectively inhibit the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces apoptosis and inhibits the growth of pancreatic, non-small cell lung, and colorectal cancer xenograft tumors.
| Supplier | Alfa Cytology |
|---|---|
| Product # | PC0059 |
| Pricing | 1 mg, 5 mg,10 mg, 25 mg,50 mg, 100 mg, inquire |